Aug 10, 2026 08:04AM
Jul 20, 2026 06:50AM
Jul 15, 2026 06:04AM
Jul 13, 2026 02:31PM
Jul 1, 2026 04:30AM
Jun 8, 2026 06:56AM
May 12, 2026 07:14AM Moonlake Immunotherapeutics (MLTX) PT Raised to $30 at Needham
May 11, 2026 07:12AM
May 11, 2026 06:29AM
Apr 15, 2026 07:20AM
Mar 31, 2026 07:40AM
Mar 30, 2026 08:21AM
Mar 23, 2026 05:43AM
Mar 19, 2026 03:42AM Rothschild Redburn Upgrades Moonlake Immunotherapeutics (MLTX) to Buy
Mar 11, 2026 06:27AM
Mar 3, 2026 07:00AM
Mar 2, 2026 07:00AM
Feb 9, 2026 10:01AM
Feb 3, 2026 06:45AM
Jan 15, 2026 02:26AM
Jan 9, 2026 05:51AM BTIG Upgrades Moonlake Immunotherapeutics (MLTX) to Buy
Jan 8, 2026 08:51AM
Jan 8, 2026 08:05AM
Nov 21, 2025 06:40AM
Nov 5, 2025 07:11AM
Nov 3, 2025 06:38AM
Oct 7, 2025 09:04AM
Oct 3, 2025 09:56AM Increasing unusual call option volume: MLTX RVPH OVID KDK LAC PLUG CAN TD GSRT FINV
Oct 2, 2025 06:42AM
Sep 30, 2025 04:27PM
Sep 30, 2025 07:11AM
Sep 30, 2025 06:42AM
Sep 29, 2025 04:38PM
Sep 29, 2025 02:51PM
Sep 29, 2025 01:57PM Jefferies Downgrades Moonlake Immunotherapeutics (MLTX) to Hold, 'Growing Uncertainty in SLK Path Fwd and Dimmed Commercial Outlook'
Sep 29, 2025 06:56AM
Sep 29, 2025 06:41AM
Sep 29, 2025 01:10AM
Sep 29, 2025 12:49AM
Sep 22, 2025 06:12AM
Sep 11, 2025 08:18AM
Aug 5, 2025 12:26PM Guggenheim on 'Best Idea' Moonlake Immunotherapeutics (MLTX): 'We Continue To Anticipate Highly Positive Pivotal HS Readout Around Sept (2H)'
Aug 5, 2025 07:49AM
Aug 5, 2025 05:40AM
Jul 28, 2025 05:48AM
Jun 5, 2025 03:35PM
Jun 5, 2025 05:58AM
Jun 3, 2025 09:31AM
Jun 3, 2025 05:52AM Guggenheim: Moonlake Immunotherapeutics (MLTX) remains our Best Idea
Jun 2, 2025 04:52PM

435,213 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All